Who owns MARINUS PHARMACEUTICALS INC?
- CUSIP Number: 56854q200
Tip: Access positions for across all investors
Analyze quarterly positions in Marinus Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Marinus Pharmaceuticals stock
Who bought or sold MARINUS PHARMACEUTICALS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Beryl Capital Management | 4.2M | $2.3M | 100% | Dec 2024 |
|
| Morgan Stanley | 3.3M | $1.8M | 1899% | Dec 2024 |
|
| Oddo Bhf Asset Management Sas | 2.7M | $1.4M | 100% | Dec 2024 |
|
| Bain Capital Life Sciences Investors | 2.7M | $1.4M | 0% | Dec 2024 |
|
| Standard Life Aberdeen | 2.7M | $1.4M | 0% | Dec 2024 |
|
| Vanguard Group | 2.6M | $1.4M | -7% | Dec 2024 |
|
| Woodline Partners | 2.3M | $1.2M | 85% | Dec 2024 |
|
| GSA Capital Partners | 1.8M | $983k | 81% | Dec 2024 |
|
| Tang Capital Management | 1.6M | $879k | -65% | Dec 2024 |
|
| BlackRock | 884k | $473k | -52% | Dec 2024 |
|
| Acadian Asset Management | 697k | $371k | -23% | Dec 2024 |
|
| Geode Capital Management | 529k | $283k | -7% | Dec 2024 |
|
| Citadel Advisors | 521k | $279k | 81% | Dec 2024 |
|
| Jpmorgan Chase & Co | 488k | $261k | 266% | Dec 2024 |
|
| Susquehanna International | 465k | $249k | 100% | Dec 2024 |
|
| Schroder Investment Management Group | 290k | $153k | 0% | Dec 2024 |
|
| UBS Group | 259k | $139k | 11368% | Dec 2024 |
|
| Royal Bank of Canada | 249k | $157k | 303% | Dec 2024 |
|
| Millennium Management | 239k | $128k | -50% | Dec 2024 |
|
| State Street Corporation | 223k | $119k | 8% | Dec 2024 |
|
| XTX Topco | 220k | $118k | 1565% | Dec 2024 |
|
| Deltec Asset Management | 200k | $107k | 100% | Dec 2024 |
|
| Northern Trust | 113k | $61k | -4% | Dec 2024 |
|
| Gabelli Securities | 100k | $54k | 100% | Dec 2024 |
|
| Virtu Financial | 67k | $36k | 100% | Dec 2024 |
|
| Goldman Sachs Group | 52k | $28k | 31% | Dec 2024 |
|
| T. Rowe Price Associates | 44k | $24k | 0% | Dec 2024 |
|
| Harvest Investment Services | 41k | $22k | 100% | Dec 2024 |
|
| Hrt Financial | 31k | $16k | 100% | Dec 2024 |
|
| Tower Research Capital | 23k | $12k | 69% | Dec 2024 |
|
| Two Sigma Investments | 23k | $12k | -52% | Dec 2024 |
|
| Point72 Asia | 21k | $11k | 8% | Dec 2024 |
|
| Jacobs Levy Equity Management | 20k | $11k | -95% | Dec 2024 |
|
| Engineers Gate Manager | 16k | $8.6k | -46% | Dec 2024 |
|
| Qube Research & Technologies | 13k | $6.9k | -62% | Dec 2024 |
|
| Commonwealth Equity Services | 13k | $7.0k | -1% | Dec 2024 |
|
| Perfromance Wealth Partners | 11k | $5.9k | 0% | Dec 2024 |
|
| Simplex Trading | 9.5k | $5.0k | -82% | Dec 2024 |
|
| Group One Trading | 6.3k | $3.4k | -46% | Dec 2024 |
|
| Advisor Group Holdings | 5.7k | $10k | -48% | Dec 2024 |
|
| Coppell Advisory Solutions | 3.1k | $31k | 0% | Dec 2024 |
|
| Federated Investors | 2.3k | $1.2k | -39% | Dec 2024 |
|
| Wells Fargo & Company | 1.8k | $963.000000 | 0% | Dec 2024 |
|
| Bank of America Corporation | 1.7k | $885.512100 | -99% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.3k | $707.005600 | 100% | Dec 2024 |
|
| 1620 Investment Advisors | 1.0k | $535.000000 | 0% | Dec 2024 |
|
| Citigroup | 932.00 | $498.992800 | -29% | Dec 2024 |
|
| Zurcher Kantonalbank | 275.00 | $146.987500 | -83% | Dec 2024 |
|
| Barclays | 54.00 | $0 | -82% | Dec 2024 |
|
| SBI Securities | 50.00 | $27.000000 | 100% | Dec 2024 |
|
| Point72 | 21.00 | $10.999800 | -25% | Dec 2024 |
|
Who sold out of Marinus Pharmaceuticals?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Suvretta Capital Management | Sep 2024 | 5.1M | $8.9M |
| Franklin Resources | Sep 2024 | 4.7M | $8.5M |
| Sofinnova Ventures | Sep 2024 | 4.4M | $7.7M |
| Bleichroeder | Sep 2024 | 1.9M | $3.3M |
| Ikarian Capital | Sep 2024 | 706k | $1.2M |
| Lion Point Capital | Sep 2024 | 694k | $1.2M |
| Renaissance Technologies | Sep 2024 | 502k | $883k |
| Bank Of Montreal | Sep 2024 | 430k | $608k |
| Prudential Financial | Sep 2024 | 385k | $678k |
| Boothbay Fund Management | Sep 2024 | 186k | $327k |
| D. E. Shaw & Co | Sep 2024 | 179k | $315k |
| Jane Street | Sep 2024 | 76k | $133k |
| Squarepoint Ops | Sep 2024 | 74k | $131k |
| Schonfeld Strategic Advisors | Sep 2024 | 68k | $119k |
| Values First Advisors | Sep 2024 | 67k | $118k |
| Pensionmark Financial Group | Sep 2024 | 59k | $104k |
| Assenagon Asset Management | Dec 2024 | 57k | $31k |
| Bridgeway Capital Management | Sep 2024 | 50k | $88k |
| Algert Coldiron Investors | Sep 2024 | 29k | $52k |
| Two Sigma Advisers | Sep 2024 | 20k | $35k |
| Atria Investments | Sep 2024 | 13k | $23k |
| Wolverine Trading | Sep 2024 | 13k | $24k |
| China Universal Asset Management | Sep 2024 | 11k | $19k |
| Balyasny Asset Management | Sep 2024 | 10k | $18k |
| FMR | Sep 2024 | 6.8k | $12k |
| Russell Investments | Sep 2024 | 2.6k | $4.5k |
| Mizuho Securities USA | Sep 2024 | 2.4k | $627k |
| Mirae Asset Global Investments | Sep 2024 | 2.0k | $3.7k |
| Principal Securities | Sep 2024 | 457.00 | $804.000100 |
| Absolute Investment Management | Sep 2024 | 351.00 | $618.005700 |
| Daiwa Securities Group | Sep 2024 | 202.00 | $0 |
| Fifth Third Bancorp | Dec 2024 | 115.00 | $61.996500 |